Dezhan Healthcare Company Limited (SHE:000813)

China flag China · Delayed Price · Currency is CNY
4.070
-0.050 (-1.21%)
Feb 3, 2026, 3:04 PM CST
35.67%
Market Cap8.54B +28.4%
Revenue (ttm)389.51M -24.7%
Net Income-89.53M
EPS-0.04
Shares Out2.10B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume64,970,970
Average Volume52,298,994
Open4.520
Previous Close4.120
Day's Range4.030 - 4.520
52-Week Range2.790 - 5.260
Beta0.50
RSI55.28
Earnings DateApr 25, 2026

About Dezhan Healthcare Company

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It also involved in the provision of biological peptides, industrial hemp, and medical s... [Read more]

Sector Healthcare
Founded 1980
Employees 1,054
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000813
Full Company Profile

Financial Performance

Financial Statements